Morningside Pharmaceuticals Limited

The large node is Morningside Pharmaceuticals Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 7

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

From Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.

• NHS National Generic Pharmaceuticals - Wave 16a Buyer: NHS England £15,529,352 2026-08-27 Source: Find a Tender

  NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…

  Framework
• Anti-Infective Drugs 3 Buyer: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards Value not published Date not published CPV 33600000 Source: Find a Tender

  Generic Anti-Infective Drugs
• Oncology Generics Medicines Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") Value not published Date not published CPV 33600000 Source: Find a Tender

  This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in secti…

  Framework
• NP36126 Antibiotic & Genito Urinary Medicines Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) Value not published Date not published CPV 33600000 Source: Find a Tender

  Supply of Antibiotic & Genito Urinary Medicines to NHS Scotland.

  Framework
• NHS National Branded Interim - 1 June 2026 Buyer: NHS England Value not published Date not published Source: Find a Tender

  Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months

  Framework
• NHS National Generics Pharmaceuticals - Supply Chain Resilience Buyer: NHS England Value not published Date not published Source: Find a Tender

  NHS National Generics Pharmaceuticals - Supply Chain Resilience Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months…

  Framework
• Generic, Branded Generic & Proprietary Medicinal Products - Group 18 Buyer: Regional Business Services Organisation, Procurement and Logistics Service Value not published Date not published CPV 33600000 Source: Find a Tender

  Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)
• Contraceptive Medicines Buyer: The Common Services Agency (more commonly known as Public Services Delivery Scotland (PSDS) Value not published Date not published CPV 33600000 Source: Find a Tender

  This Framework Agreement is for the supply of Contraceptive Medicines to health boards across NHS Scotland. The Goods have been split into five (5) categories, each of which is identified as a "Lot". Full details of each Lot is contained in…

About

Incorporated

18/12/1991

Ownership

Group

1. Morningside Pharmaceuticals Limited is controlled by Randalsun Capital Limited
   Evidence

   ceased 75-100% shares, 75-100% voting, appoints directors · notified 2021-05-21, ceased 2022-09-30 · source: Companies House PSC register
2. Randalsun Capital Limited is controlled by Nikesh Rasiklal Kotecha
   Evidence

   active 25-50% shares (trust), 25-50% voting (trust) · notified 2020-02-28 · source: Companies House PSC register

Ultimately controlled by Nikesh Rasiklal Kotecha.

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Financials

Net assets

£17,562,000

Total assets

£17,613,000

Cash

£100,000

Employees

0.47

Turnover

Not reported (small or micro-entity accounts)

Profit/loss

£13,357,000

Filed as Full accounts.

Five-year trend

Figures from accounts filed at Companies House (iXBRL), period ending 2025-12-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.

360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.

Top funders

• Department for Education · £1,000

Most recent

• Department for Education £1,0002020-04-01

Sources

Official record from Companies House. Governance Register calculates the connections.